Study details
Enrolling now
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
Washington State University
NCT IDNCT05181891ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
205
Study length
about 3.8 years
Ages
18+
Locations
1 site in WA
What this study is about
Researchers are testing whether a behavioral treatment, combined with medication (varenicline), can help people reduce their alcohol use and smoking. The trial will last 1390 days and involve about 205 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Contingency Management
- 2.Participate in Non-contingent control
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Psychiatry / Mental Health